webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Bis-PEG8-acid

  CAS No.: 1246189-43-4   Cat No.: BADC-00907   Purity: ≥95% 4.5  

Bis-PEG8-acid is a PEG linker containing two terminal carboxylic acid groups. The terminal carboxylic acids can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The hydrophilic PEG spacer increases solubility in aqueous media.

Bis-PEG8-acid

Structure of 1246189-43-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C20H38O12
Molecular Weight
470.51
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years)

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
HOOC-PEG7-CH2CH2COOH; HOOCCH2CH2O-PEG7-CH2CH2COOH; 4,7,10,13,16,19,22,25-Octaoxaoctacosanedioic acid; Bis-PEG8-COOH; 4,7,10,13,16,19,22,25-Octaoxaoctacosane-1,28-dioic Acid; Di-Acid-PEG8
IUPAC Name
3-[2-[2-[2-[2-[2-[2-[2-(2-carboxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C(COCCOCCOCCOCCOCCOCCOCCOCCC(=O)O)C(=O)O
InChI
InChI=1S/C20H38O12/c21-19(22)1-3-25-5-7-27-9-11-29-13-15-31-17-18-32-16-14-30-12-10-28-8-6-26-4-2-20(23)24/h1-18H2,(H,21,22)(H,23,24)
InChIKey
IRTAMFHIULAGCS-UHFFFAOYSA-N
Density
1.179±0.06 g/cm3 (Predicted)
Solubility
Soluble in DMSO
Appearance
Pale Yellow or Colorless Oily Matter
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature, or blue ice upon request.
Storage
Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years)
Boiling Point
601.8±55.0°C (Predicted)

Bis-PEG8-acid, a versatile bifunctional polyethylene glycol derivative, finds extensive applications in biotechnology and pharmaceutical sectors. Here are four key applications of Bis-PEG8-acid presented with elevated levels of perplexity and burstiness:

Drug Delivery Systems: Central to pharmaceutical advancements, Bis-PEG8-acid plays a pivotal role in crafting sophisticated drug delivery systems. Its inherent hydrophilicity and flexibility contribute to enhancing the solubility and stability of therapeutic agents, ensuring precise delivery to targeted areas. This optimization leads to heightened bioavailability and reduced adverse effects of the medication, offering a paradigm shift in drug administration.

Protein Modification: Delving into the realm of protein engineering, Bis-PEG8-acid emerges as a crucial player in protein modification endeavors. By leveraging this compound, scientists can enhance the stability and solubility of proteins, thus extending the half-life of therapeutic proteins in circulation. This augmentation not only amplifies the efficacy of therapeutic proteins but also mitigates their immunogenicity, elevating their safety profile for clinical applications.

Surface Coating: Employed extensively in the surface coating of medical devices and implants, Bis-PEG8-acid stands as a cornerstone in minimizing biofouling and enhancing biocompatibility. By creating a hydrophilic shield, it prevents the attachment of proteins and cells, consequently reducing the risks of infections and immune reactions. This indispensable application is instrumental in preserving the functionality and durability of medical implants, ensuring optimal performance and patient well-being.

Bioconjugation: In the intricate world of bioconjugation techniques, Bis-PEG8-acid serves as a vital linker molecule, facilitating the attachment of drugs, dyes, or functional molecules to biomolecules like antibodies and peptides. This innovation enables the development of targeted therapies and diagnostic tools by refining the specificity and functionality of bioconjugates. The inclusion of Bis-PEG8-acid guarantees that the conjugated molecules maintain their activity and stability.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: ε-Amanitin | 5-Maleimidovalericacid-NHS | Dideoxy-amanitin | Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA | Acid-PEG1-bis-PEG3-BCN | Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester | Fmoc-NH-ethyl-SS-propionic NHS ester | Fmoc-NH-PEG2-NH2 | Bis-PEG6-NHS ester | Bis-PEG2-PFP ester | Bis-PEG8-acid
Send Inquiry
Verification code
Inquiry Basket